Current language:
- GA Gaeilge
The translation of this page has been generated by machine translation.
Machine translations can contain errors potentially reducing clarity and accuracy; the Ombudsman accepts no liability for any discrepancies. For the most reliable information and legal certainty, please refer to the source version in English linked above.
For more information please consult our language and translation policy.
Machine translations can contain errors potentially reducing clarity and accuracy; the Ombudsman accepts no liability for any discrepancies. For the most reliable information and legal certainty, please refer to the source version in English linked above.
For more information please consult our language and translation policy.
Diúltú páirteach rochtain phoiblí a thabhairt ar Thuarascálacha ar Staidéar Cliniciúil a bhaineann le formheas táirge íocshláinte (Humira) chun Galar Crohn a chóireáil
Case opened
Case OI/3/2014/FOR - Opened on Wednesday | 16 April 2014 - Decision on Wednesday | 08 June 2016 - Institution concerned European Medicines Agency ( No further inquiries justified ) - Country France
Diúltú páirteach rochtain phoiblí a thabhairt ar Thuarascálacha ar Staidéar Cliniciúil a bhaineann
le formheas táirge íocshláinte (Humira) chun Galar Crohn a chóireáil